MEMANTIN 20 mg Tablets

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(14)

Sergey Ilyasov

PsychiatryNeurology7 years of experience

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and adolescents. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

Book a video appointment
€106
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use Memantin Neuropharma

Contents of the leaflet

  1. Leaflet attached to the packaging: information for the user
  2. Memantin NeuroPharma, 20 mg, coated tablets
    1. Read the leaflet carefully before taking the medicine, as it contains important information for the patient.
    2. Table of contents of the leaflet:
  3. What is Memantin NeuroPharma and what is it used for
    1. How Memantin NeuroPharma works
    2. What Memantin NeuroPharma is used for
  4. Important information before taking Memantin NeuroPharma
    1. When not to take Memantin NeuroPharma
    2. Warnings and precautions
    3. Children and adolescents
    4. Memantin NeuroPharma and other medicines
    5. Taking Memantin NeuroPharma with food and drink
    6. Pregnancy and breastfeeding
    7. Driving and using machines
    8. Memantin NeuroPharma contains lactose
  5. How to take Memantin NeuroPharma
    1. Dosage
    2. Dosage in patients with kidney function disorders
    3. Method of administration
    4. Duration of treatment
    5. Taking a higher dose of Memantin NeuroPharma than recommended
    6. Missing a dose of Memantin NeuroPharma
  6. Possible side effects
    1. Common (may affect up to 1 in 10 people):
    2. Uncommon (may affect up to 1 in 100 people):
    3. Rare (may affect up to 1 in 10,000 people):
    4. Unknown (frequency cannot be estimated from the available data):
    5. Reporting side effects
  7. How to store Memantin NeuroPharma
  8. Contents of the packaging and other information
    1. What Memantin NeuroPharma contains
    2. What Memantin NeuroPharma looks like and contents of the pack
    3. Marketing authorization holder and manufacturer
    4. Manufacturer
    5. Date of the last revision of the leaflet:

Leaflet attached to the packaging: information for the user

Memantin NeuroPharma, 20 mg, coated tablets

Memantine hydrochloride

Read the leaflet carefully before taking the medicine, as it contains important information for the patient.

  • Keep this leaflet, so you can read it again if you need to.
  • If you have any doubts, consult your doctor or pharmacist.
  • This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
  • If the patient experiences any side effects, including those not listed in this leaflet, they should tell their doctor or pharmacist. See section 4.

Table of contents of the leaflet:

  • 1. What is Memantin NeuroPharma and what is it used for
  • 2. Important information before taking Memantin NeuroPharma
  • 3. How to take Memantin NeuroPharma
  • 4. Possible side effects
  • 5. How to store Memantin NeuroPharma
  • 6. Contents of the packaging and other information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What is Memantin NeuroPharma and what is it used for

How Memantin NeuroPharma works

Memantin NeuroPharma contains the active substance memantine hydrochloride. It belongs to the group of anti-dementia medicines. Memory loss in Alzheimer's disease is caused by disturbances in the transmission of nerve impulses that carry information in the brain. In the brain, there are so-called N-methyl-D-aspartate (NMDA) receptors that participate in the transmission of nerve signals important for the learning process and memory. Memantin NeuroPharma belongs to a group of medicines called NMDA receptor antagonists. Memantin NeuroPharma, by affecting NMDA receptors, improves the transmission of nerve impulses and memory.

What Memantin NeuroPharma is used for

Memantin NeuroPharma is used to treat patients with moderate to severe Alzheimer's disease.

2. Important information before taking Memantin NeuroPharma

When not to take Memantin NeuroPharma

Warnings and precautions

Before starting treatment with Memantin NeuroPharma, the patient should discuss it with their doctor or pharmacist:

  • in the case of patients who have had seizures in the past;
  • in the case of patients who have recently had a heart attack (myocardial infarction) or suffer from congestive heart failure or uncontrolled hypertension (high blood pressure).

In these situations, treatment with Memantin NeuroPharma should be carried out under close medical supervision, and the doctor should regularly assess the effects of the treatment. During the administration of memantine to patients with kidney function disorders (kidney problems), the doctor should carefully monitor kidney function and, if necessary, adjust the dosage of the medicine. The patient should avoid taking medicines such as amantadine (for the treatment of Parkinson's disease), ketamine (a substance usually used as an anesthetic), dextromethorphan (usually used to treat cough), and other medicines from the group of NMDA receptor antagonists.

Children and adolescents

Memantin NeuroPharma is not recommended for children and adolescents under 18 years of age.

Memantin NeuroPharma and other medicines

The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. In particular, taking Memantin NeuroPharma may cause changes in the action and require modification of the dosage by the doctor of the following medicines:

  • amantadine, ketamine, dextromethorphan;
  • dantrolene, baclofen;
  • cimetidine, ranitidine, procainamide, quinidine, quinine, nicotine;
  • hydrochlorothiazide (and all combination medicines containing hydrochlorothiazide);
  • anticholinergic agents (substances usually used to treat movement disorders or intestinal cramps);
  • antiepileptic medicines (substances used to prevent and stop seizures);
  • barbiturates (substances mainly used as sleep aids);
  • dopaminergic agonists (substances such as L-dopa, bromocriptine);
  • neuroleptics (substances used to treat mental disorders);
  • oral anticoagulants.

In the event of hospitalization, the patient should inform their doctor that they are taking Memantin NeuroPharma.

Taking Memantin NeuroPharma with food and drink

The patient should inform their doctor if they have recently made or plan to make significant changes to their diet (e.g., switching from a normal diet to a strict vegetarian diet) or if they have been diagnosed with renal tubular acidosis (RTA, excessive concentration of acidic substances in the blood due to kidney dysfunction) or severe urinary tract infections (structures through which urine flows). In these cases, the doctor may need to adjust the dosage of the medicine.

Pregnancy and breastfeeding

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine. Pregnancy Memantine should not be used during pregnancy. Breastfeeding Women taking Memantin NeuroPharma should not breastfeed.

Driving and using machines

The doctor should inform the patient whether their condition allows them to drive or use machines safely. Memantin NeuroPharma may also affect reaction speed, making it inadvisable to drive or use machines.

Memantin NeuroPharma contains lactose

If the patient has an intolerance to some sugars, they should consult their doctor before taking this medicine.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take Memantin NeuroPharma

This medicine should always be taken as directed by the doctor. If the patient has any doubts, they should consult their doctor or pharmacist.

Dosage

The recommended dose of Memantin NeuroPharma for adults and the elderly is 20 mg per day. To minimize the risk of side effects, this dose is achieved gradually, according to the following treatment schedule. Initially, the patient starts treatment with a dose of 5 mg once a day. This dose is increased by 5 mg every week until the recommended maintenance dose of 20 mg once a day is reached, which should be achieved at the beginning of the 4th week of treatment.

Dosage in patients with kidney function disorders

In patients with impaired kidney function, the doctor determines the appropriate dosage of the medicine. In such cases, regular monitoring of kidney function is necessary at specified time intervals, according to the doctor's instructions.

Method of administration

Memantin NeuroPharma should be taken orally, once a day. To ensure the treatment is effective, the medicine should be taken regularly every day at the same time. The tablets should be swallowed with water. This medicine can be taken with or without food.

Duration of treatment

Treatment should be continued as long as it is effective. The doctor should regularly assess the course of treatment.

Generally, taking too much Memantin NeuroPharma does not pose a risk to health. In such cases, the patient may experience intensified side effects described in section 4 "Possible side effects". In the event of significant overdose of Memantin NeuroPharma, the patient should contact their doctor or another doctor, as appropriate action may be necessary.

Missing a dose of Memantin NeuroPharma

If the patient forgets to take a dose, they should take the next dose of Memantin NeuroPharma at the usual time. The patient should not take a double dose to make up for the missed dose. If the patient has any further doubts about taking this medicine, they should consult their doctor or pharmacist.

4. Possible side effects

Like all medicines, Memantin NeuroPharma can cause side effects, although not everybody gets them. The observed side effects are usually mild to moderate.

Common (may affect up to 1 in 10 people):

  • Headache, drowsiness, constipation, elevated liver enzyme levels, dizziness, balance disorders, shallow breathing, high blood pressure, and hypersensitivity to the medicine.

Uncommon (may affect up to 1 in 100 people):

  • Fatigue, fungal infections, confusion, hallucinations, vomiting, abnormal gait, heart failure, and venous thrombosis/thromboembolism.

Rare (may affect up to 1 in 10,000 people):

  • Seizures.

Unknown (frequency cannot be estimated from the available data):

  • Pancreatitis, hepatitis, and psychotic reactions.

Alzheimer's disease is associated with depression, suicidal thoughts, and suicide. Such cases have been reported in patients treated with Memantin NeuroPharma.

Reporting side effects

If the patient experiences any side effects, including those not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. By reporting side effects, more information can be collected on the safety of the medicine. Side effects can also be reported to the marketing authorization holder.

5. How to store Memantin NeuroPharma

The medicine should be stored out of sight and reach of children. Do not use this medicine after the expiry date stated on the packaging and blister after "(EXP)". The expiry date refers to the last day of the specified month. There are no special precautions for storing the medicinal product. Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Memantin NeuroPharma contains

The active substance is memantine hydrochloride. Each coated tablet contains 20 mg of memantine hydrochloride, equivalent to 16.62 mg of memantine. The other ingredients are lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc, silicon dioxide, hypromellose, macrogol 4000, titanium dioxide (E 171).

What Memantin NeuroPharma looks like and contents of the pack

Memantin NeuroPharma 20 mg coated tablets are white or almost white, round, biconvex coated tablets with a cross-shaped break line on one side. The length of the tablet is 12 mm. The tablet can be divided into four equal doses. Memantin NeuroPharma coated tablets are packaged in blisters. Memantin NeuroPharma is available in packs containing 7, 28, 30, 42, 50, 56, 98, or 100 coated tablets. Hospital pack: 420 coated tablets (bulk pack). Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

neuraxpharm Arzneimittel GmbH, Elisabeth-Selbert-Str. 23, 40764 Langenfeld, Germany

Manufacturer

Laboratorios Lesvi, S.L., Avda. Barcelona 69, 08970 Sant Joan Despí (Barcelona), Spain To obtain more detailed information, please contact the representative of the marketing authorization holder in Poland:Neuraxpharm Polska sp. z o.o., ul. Domaniewska 37, 02-672 Warsaw, [email protected]

Date of the last revision of the leaflet:

Online doctors for Memantin Neuropharma

Discuss questions about Memantin Neuropharma, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

Doctor
5.0(14)

Sergey Ilyasov

PsychiatryNeurology7 years of experience

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and adolescents. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

Book a video appointment
€106
Doctor
5.0(22)

Taisiia Proida

Psychiatry7 years of experience

Taisiia Proida is a general practitioner with a specialization in mental health and a cognitive behavioral therapist (CBT), a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care. She specialises in consultations and ongoing support for a wide range of mental health concerns, including: 

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders. She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

Book a video appointment
€156
Doctor
5.0(6)

Anastasiia Hladkykh

Psychiatry15 years of experience

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Book a video appointment
€156
Doctor
0.0(0)

Maria Martelli

AnaesthesiologyPain medicine12 years of experience

Dr Maria Martelli is a medical doctor specialising in anaesthesiology and pain medicine. She provides online consultations for adults, focusing on the assessment and management of acute, chronic, and complex pain conditions, as well as supportive care in serious illness. She graduated from the Medical University of Silesia in Katowice and completed her specialisation in Anaesthesiology and Intensive Care. Alongside hospital work, she has extensive experience in home and inpatient hospice care, supporting patients with severe pain and advanced disease. Since 2021, she has been a certified specialist and continues to work in anaesthesiology, intensive care, and pain treatment. Patients consult her for: 

  • Chronic pain lasting more than 3 months (musculoskeletal, neuropathic, mixed pain).
  • Acute pain requiring medical assessment and treatment planning.
  • Post-operative pain and recovery support.
  • Cancer-related pain and symptom relief.
  • Palliative care support and quality-of-life improvement.
  • Adjustment and optimisation of pain medication.
  • Second opinions for complex or treatment-resistant pain.

Dr Martelli takes a structured, evidence-based approach, carefully analysing symptoms, previous treatments, and overall health status. Her consultations focus on realistic pain control goals, safety of therapy, and improving daily functioning. She is especially attentive to patients living with long-term pain or serious illness, providing clear explanations, compassionate guidance, and medically sound recommendations adapted to each individual situation.

Book a video appointment
€105
Doctor
5.0(1)

Daria Portnova

Psychiatry31 years of experience

Dr Daria Portnova is a psychiatrist and psychotherapist with over 30 years of clinical experience. She works with adults and adolescents aged 14 and over, providing online psychiatric and psychotherapeutic consultations. In her practice, Dr Portnova supports patients facing the onset of mental health conditions, chronic psychiatric disorders, psychotic symptoms, trauma-related states, and complex emotional crises. Her work is structured and safety-focused, with an emphasis on stabilisation, accurate diagnosis, and long-term improvement in quality of life. Patients consult Dr Daria Portnova for the following concerns: 

  • existential crises and complex life situations;
  • loss, grief, and emotional exhaustion;
  • relationship difficulties, separation, and divorce;
  • psychological and psychiatric trauma, including complex PTSD (cPTSD);
  • anxiety disorders: generalised anxiety disorder and panic disorder;
  • social anxiety and social phobia;
  • obsessive-compulsive disorder (OCD);
  • sleep disorders;
  • depressive disorders;
  • bipolar affective disorder;
  • schizoaffective disorder;
  • schizophrenia;
  • personality disorders.

Dr Portnova combines psychiatric assessment with a psychotherapeutic approach. She works with evidence-based methods, including cognitive behavioural therapy (CBT) and third-wave approaches such as ACT, FACT, and CFT. Consultations are focused on clear clinical understanding, practical recommendations, and ongoing support over time.

Book a video appointment
€116
Doctor
5.0(1)

Pedro Alvarez Guerrero

Psychiatry8 years of experience

Dr. Alvarez Guerrero graduated in Medicine from the San Pablo CEU University in Madrid. He subsequently completed his specialization in Psychiatry in the Department of Psychiatry at Hospital Sant Joan de Deu in Manresa (Barcelona), where over the course of four years he acquired solid training in the bio-psycho-social model, developing his expertise across the different areas of mental health.

During his residency, he undertook training placements at Hospital Clínic de Barcelona, where he trained for several months in the psychiatric consultation-liaison unit. He also completed another placement at Hospital de Cruces in Bilbao, in the first-episode psychosis unit.

Throughout his professional career, Dr. Alvarez Guerrero has sought to complement his medical training with psychotherapeutic tools that allow him to address mental health disorders from a comprehensive perspective. For this reason, he specialized in Brief Strategic Psychotherapy through the Spanish Society of Psychosomatic Medicine and Psychotherapy, an approach focused on targeted and effective interventions.

With the aim of deepening his knowledge and promoting the rational use of treatments, he also completed a Master’s Degree in Psychopharmacology at the University of Valencia, which has enabled him to rigorously integrate the most up-to-date scientific evidence into the clinical management of psychopharmacological treatments.

He has also shown a particular interest in the field of legal psychiatry, completing an Official Master’s Degree in Legal, Forensic and Criminological Psychopathology at the Universitat Internacional de Catalunya. This training has allowed him to acquire the necessary competencies for the preparation of psychiatric expert reports in judicial and medico-legal contexts, thereby broadening the scope of his professional activity.

Book a video appointment
€116

Get Memantin Neuropharma Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for Memantin Neuropharma?

Memantin Neuropharma requires a prescription in Poland. You can check with a doctor online whether this medicine may be appropriate for your situation.

What is the active substance in Memantin Neuropharma?

The active ingredient in Memantin Neuropharma is memantine. This information helps identify medicines with the same composition but different brand names.

Who manufactures Memantin Neuropharma?

Memantin Neuropharma is manufactured by Laboratorios Lesvi S.L. neuraxpharm Arzneimittel GmbH. Pharmacy brands and packaging may differ depending on the distributor.

Which doctors can assess the use of Memantin Neuropharma online?

Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether Memantin Neuropharma is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

How to buy Memantin Neuropharma in Spain?

Spain has a well-developed healthcare infrastructure across major cities such as Madrid, Barcelona, Valencia, and Seville. Pharmacies are widely available and operate under strict regulations, ensuring access to prescribed medications.

You can buy Memantin Neuropharma in Madrid, Barcelona, Seville, or Valencia at any local pharmacy with a valid prescription.

To obtain a prescription, you can use Oladoctor:

What are the alternatives to Memantin Neuropharma?

Other medicines with the same active substance (memantine) include Auromemo, Auromemo, Biomentin. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media